Search

Search Constraints

You searched for: Author/Creator Cote, Gregory

Search Results

1. ACTR-31. PHASE 1 STUDY OF AG-881, AN INHIBITOR OF MUTANT IDH1 AND IDH2: RESULTS FROM THE RECURRENT/PROGRESSIVE GLIOMA POPULATION. (5th November 2018)

3. Clinical and Molecular Analysis of Pathologic Fracture-associated Osteosarcoma: MicroRNA profile Is Different and Correlates with Prognosis. Issue 9 (September 2019)

4. Clinical outcomes for patients after surgery and radiation therapy for mesenchymal chondrosarcomas. Issue 8 (28th October 2016)

5. Direct Endoscopic Necrosectomy With and Without Hydrogen Peroxide for Walled-off Pancreatic Necrosis: A Multicenter Comparative Study. (3rd April 2021)

6. EP294/#883 Elimusertib, an oral ataxia telangiectasia and RAD3-related inhibitor, in advanced gynecologic cancers with DNA damage response defects. (4th December 2022)

7. Evaluation of P‐glycoprotein (Pgp) expression in human osteosarcoma by high‐throughput tissue microarray. Issue 9 (2nd February 2016)

8. Imatinib mesylate lacks efficacy in relapsed/refractory peripheral T cell lymphoma. Issue 4 (April 2015)

9. Interim results of an ongoing Phase I, dose escalation study of MGA271 (Fc-optimized humanized anti-B7-H3 monoclonal antibody) in patients with refractory B7-H3-expressing neoplasms or neoplasms whose vasculature expresses B7-H3. Issue 2 (December 2015)

10. Interim results of an ongoing Phase I, dose escalation study of MGA271 (Fc-optimized humanized anti-B7-H3 monoclonal antibody) in patients with refractory B7-H3-expressing neoplasms or neoplasms whose vasculature expresses B7-H3. (4th November 2015)